Literature DB >> 3069255

Immunomodulatory effects of pulmonary surfactant on natural killer cell and antibody-dependent cytotoxicity.

M L Wilsher1, D A Hughes, P L Haslam.   

Abstract

Alveolar natural killer (NK) cells are functionally weak compared to their blood and interstitial counterparts. Having previously demonstrated that pulmonary surfactant suppresses lymphocyte responses to a variety of stimuli we sought in this study to determine if surfactant exerts a similar suppressive effect on cytotoxic function. Lipids were purified from the bronchoalveolar lavage (BAL) fluid from normal human volunteers. Human peripheral blood lymphocytes (n = 10 subjects) were cultured overnight in the presence or absence of purified BAL lipids (0.2 mg/ml), or pure preparations of phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylglycerol (PG) (0.4 mg/ml). Standard NK and antibody-dependent cytotoxicity (ADCC) assays were performed using K562 and Chang target cells. The pooled BAL lipids significantly suppressed both NK (P less than 0.01) and ADCC (P = 0.01) activity in a dose-dependent manner. Whereas pure PC did not exert a significant effect, PG significantly suppressed (P less than 0.01) and PE significantly enhanced (P less than 0.01) both cytotoxic functions. There was no change in the expression of leu 7 or 11b antigens by lymphocytes after culture in BAL lipids. These results suggest that under normal circumstances pulmonary surfactant may suppress alveolar cytotoxic responses but that imbalances in the phospholipid profile might affect this immunoregulatory property.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069255      PMCID: PMC1542016     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Mechanisms of the renal response to plasma volume expansion.

Authors:  E L ATKINS; J W PEARCE
Journal:  Can J Biochem Physiol       Date:  1959-01

2.  Immunosuppressive activity of canine pulmonary surface active material.

Authors:  M J Ansfield; H B Kaltreider; B J Benson; J L Caldwell
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

3.  Physical and physiological properties of dry lung surfactant.

Authors:  C J Morley; A D Banhham; P Johnson; G D Thorburn; G Jenkin
Journal:  Nature       Date:  1978-01-12       Impact factor: 49.962

4.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

5.  Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers.

Authors:  R B Low; G S Davis; M S Giancola
Journal:  Am Rev Respir Dis       Date:  1978-11

6.  Peturbation of lymphocyte response to concanavalin A by exogenous cholesterol and lecithin.

Authors:  B Rivnay; A Globerson; M Shinitzky
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

7.  Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages.

Authors:  D B Ettensohn; N J Roberts
Journal:  Am Rev Respir Dis       Date:  1983-09

8.  Natural cytotoxic activity in human lungs.

Authors:  C Bordignon; F Villa; A Vecchi; R Giavazzi; M Introna; R Avallone; A Mantovani
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

Review 9.  Phospholipid methylation and biological signal transmission.

Authors:  F Hirata; J Axelrod
Journal:  Science       Date:  1980-09-05       Impact factor: 47.728

10.  Identification of the immunosuppressive components of canine pulmonary surface active material.

Authors:  M J Ansfield; B J Benson
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  7 in total

1.  Immunosuppression by pulmonary surfactant: mechanisms of action.

Authors:  M L Wilsher; D J Parker; P L Haslam
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

Review 2.  NK cells in immunotolerant organs.

Authors:  Haoyu Sun; Cheng Sun; Zhigang Tian; Weihua Xiao
Journal:  Cell Mol Immunol       Date:  2013-04-08       Impact factor: 11.530

3.  Immunogenicity of surfactant. I. Human alveolar surfactant.

Authors:  D S Strayer; M Hallman; T A Merritt
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

Review 4.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

5.  Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.

Authors:  Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-11       Impact factor: 10.793

Review 6.  SP-D and regulation of the pulmonary innate immune system in allergic airway changes.

Authors:  L R Forbes; A Haczku
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

7.  Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.

Authors:  Markus Fehrholz; Kirsten Glaser; Silvia Seidenspinner; Barbara Ottensmeier; Tore Curstedt; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.